Hyaluronic acid-coated capecitabine nanostructures for CD44 receptor-mediated targeting in breast cancer therapy
Sruthi Laakshmi Mugundhan, M. Mothilal
Abstract
experiments. AO/PI staining also demonstrated dose-dependent apoptosis in MCF-7 breast cancer cells and validated the highly effective active targeting of HA. In addition, the formulation demonstrated good stability during storage and dilution conditions, confirming its stability as a drug delivery platform. In conclusion, HA-functionalized nanomicelles provide a biocompatible and efficient system for the targeted breast cancer therapy, enhancing the therapeutic efficacy of capecitabine.
Topics & Concepts
Hyaluronic acidCapecitabineCD44Breast cancerDrug deliveryCancer researchReceptorMedicineCancerChemistryPharmacologyInternal medicineNanotechnologyMaterials scienceBiochemistryCellColorectal cancerAnatomyNanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryProteoglycans and glycosaminoglycans research